Methods Of Administering Anti-Tnfalpha Antibodies

Patent No. EP2940044 (titled "Methods Of Administering Anti-Tnfalpha Antibodies") was filed by Abbvie Biotechnology on Jun 5, 2002. The application was issued on Jan 18, 2017.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (11)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2940044

ABBVIE BIOTECHNOLOGY
Application Number
EP15165133A
Filing Date
Jun 5, 2002
Status
Opposition Rejected
May 13, 2022
Publication Date
Jan 18, 2017